Creative Diagnostics, a reagent supplier and developer focused on biologics quality control, has announced the launch of its new Viral Nucleic Acid Residue Assay Kits (qPCR) to ensure the purity and ...
Advancing Multiple Programs in Areas of Significant Unmet Medical NeedSeveral Milestones Across Clinical Development Pipeline Expected in ...
Young biotech Dropshot Therapeutics has hooked in Etherna Immunotherapies with an RNA pact that could net up to $950 million.
As part of the agreement, Sanofi will provide Alloy with upfront license fees and near-term preclinical milestone payments up ...
STONY BROOK, NY / ACCESSWIRE / / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the completion of the buildout of ...
Increases speed to market for drug developers working on nucleic acid therapeutics.
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Ultima Genomics, Inc., a developer of an ultra-high throughput next-generation sequencing (NGS) platform, today announced that its UG 100™ was selected as the sequencing platform to enable UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback